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CASE REPORT
Maxillary Sinus Augmentation With Recombinant Human Bone
Morphogenetic Protein-2 and Particulate Allograft Without
an Absorbable Sponge: A Case Report
Andrew S. Barnett,* Carlo Maria Soardi,† and Hom-Lay Wang*
Introduction: Recently, biologic agents have been added to bone graft materials in sinus-augmentation surgeries to
accelerate the rate of regeneration. One such agent is recombinant human bone morphogenetic protein-2 (rhBMP-2) using
an absorbable collagen sponge (ACS) as a carrier. Researchers have previously shown that, not only can rhBMP-2 be suc-
cessfully added to an allograft, but that the amount of ACS used is directly related to an increase in future graft shrinkage.
There are limited data on adding rhBMP-2 to an allograft mixture without any ACS. Hence, the objective of this case report
is to provide the first histomorphometric analysis using rhBMP-2 with allograft mixture without an ACS in an effort to reduce
graft shrinkage.
Case Presentation: A patient presented requiring implants in the right posterior, but maxillary sinus pneumatization
and ridge resorption resulted in inadequate bone height. A sinus-augmentation procedure was completed using rhBMP-2
with allograft mixture without an ACS in an effort to reduce graft shrinkage; bone core biopsies were trephined at implant
placement 6 months later and underwent histologic analysis. The graft regenerated as viable, mature, mineralized bone,
and implant placement was successful.
Conclusions: To the best of the authors’ knowledge, this is the first report indicating that directly adding rhBMP-2 to
an allograft mixture without an ACS carrier is a viable supplementation to a sinus-augmentation procedure. However, long-
term randomized controlled trials are needed for proper quantitative analysis and to determine its long-term predictability and
efficacy. Clin Adv Periodontics 2014;4:175-181.
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Background
The restoration of the posterior maxilla can often be
complicated by the maxillary sinus. Accelerated bone
resorption and sinus pneumatization after tooth loss may
result in insufficient native bone height to allow for the
proper placement of an implant without compromising its
length. Although the current success rates of implants placed
in previously augmented maxillary sinuses are already high
(90%1 to 91.5%2), the addition of biologic agents with bone
graft materials has also been investigated.3-8
Bone morphogenetic proteins (BMPs) belong to the
transforming growth factor-b superfamily and are osteoin-
ductive.9 When added to sinus-augmentation procedures,
they have been shown to not only improve the quality of
the bone graft significantly, but also to accelerate the healing
process8,10-12 in a dose-dependent manner.13,14 Of concern,
recombinant human BMP-2 (rhBMP-2) is only approved
by the Food and Drug Administration for use with an
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absorbable collagen sponge (ACS), but researchers have
found a direct relationship between the number of sponges
used and the degree of shrinkage of the graftmaterial.8 If the
only approved carrier for rhBMP-2 has poor space main-
taining properties in addition to a high resorption rate, then
the amount of successful bony augmentation that can be
expected is greatly limited.
FIGURE 1 Pretreatment panoramic radiograph showing right maxillary
sinus pneumatization and ridge resorption.
FIGURE 2 Dimensions of the lateral window opening and measurement.
FIGURE 3 Collagen membrane placed against the Schneiderian
membrane.
FIGURE 4 Placement of allograft/rhBMP-2 mixture into the sinus cavity.
FIGURE 5 Placement of small-particle cancellous allograft to seal the
lateral window to promote smooth healing.
FIGURE 6 Placement of the second absorbable collagen membrane to
cover the window and protect the grafts placed.
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In the current case of a lateral window maxillary sinus
augmentation, the authors hoped to optimally reduce the
degree of shrinkage by foregoing the use of an ACS and di-
rectly adding the rhBMP-2 solution to the allograft
mixture.
Clinical Presentation
OnMarch 2, 2009, a 63-year-oldmale patient presented to
the Dental Faculty Associates clinic at the University of
Michigan School of Dentistry, Ann Arbor,Michigan, to re-
store the edentulous space in his posterior upper right sex-
tant. The patient signed a written informed consent for all
treatment. His medical history was significant for osteoar-
thritis in his hands and a systemic allergy to penicillin. His
current medications were daily doses of 20 mg atorvastatin,
325 mg aspirin, and 800 mg ibuprofen. The patient was
FIGURE 7 Primary flap closure with adequate passivity was achieved with
4-0 polyglactin 910 sutures.
FIGURE 8 Panoramic radiograph at the 2-week postoperative visit.
FIGURE 9 Panoramic radiograph at the 6-month postoperative visit
demonstrating the graft maturation.
FIGURE 10 Flap reflected, showing good bone formation.
FIGURE 11a Histologic analysis (original magnification 2) using Masson
trichrome staining method depicting a greater proportion of mineralized
bone (blue) compared with immature osteoid (red). 11b Higher magnifica-
tion (20) of Masson trichrome staining method showing mineralized bone
(blue) compared with immature osteoid (red).
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classified as American Society of Anesthesiologists Class II
physical status.15
At the initial appointment, the patient presented with
a fixed partial denture for tooth sites #2 through #5, with
tooth sites #2, #4, and #5 serving as abutments and tooth
site #5 connected through a semirigid connector. Tooth site
#2 had fractured 3mm subgingivally andwas deemed non-
restorable. The bridge was sectioned distal to tooth site #4,
and tooth site #2 was extracted with no complications; no
ridge preservation was performed at this time. The right si-
nus demonstrated significant pneumatization and ridge re-
sorption as demonstrated in the pretreatment panoramic
radiograph (Fig. 1); in the area of tooth sites #2 and #3,
mean ridge width was 9.6 mm, and mean ridge height
was 3.8 mm.
Case Management
Seven weeks after extraction, the patient was scheduled
for surgery. On the day of surgery, the patient took 500
mg azithromycin, 800 mg ibuprofen, and 180 mg pseu-
doephedrine. The patient was placed under moderate in-
travenous sedation. Local anesthesia was achieved using
three carpules of 2% lidocaine with 1:50,000 epinephrine
for local infiltrations. A full-thickness flap was raised and
a circular lateral window 10 mm in diameter was created
using high-speed electric and piezoelectric hand pieces
3 mm apical to the estimated floor of the right maxillary
sinus (Fig. 2). The Schneiderian membrane was elevated,
and an absorbable collagen membrane‡ was placed
against it to: 1) protect the membrane during bone graft
placement; 2) seal any membrane perforations that may
FIGURE 12a Histologic analysis (original magnification 2) using H&E
staining depicting viable osteocytes in newly formed bone. 12b Higher
magnification (20) of H&E staining showing viable osteocytes in newly
formed bone.
FIGURE 13 Final restoration 6 months after
implant placement. 13a Buccal view in occlusion.
13b Occlusal view. 13c Maxillary buccal view.
13d Final periapical radiograph after crown
cementation.
‡ BioMend Collagen Membrane, Zimmer Dental, Carlsbad, CA.
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exist; and 3) allow for better viewing for graft placement
(Fig. 3).
A 4:1mixed ratio of human allograftx cortical (large par-
ticle: 1 to 2mm)/cancellous (small particle: 250 to 850 mm)
mixture was hydrated with 1.05 mg rhBMP-2‖ mixed with
1 mL sterile water. The bone graft mixture was lightly
packed into the sinus cavity (Fig. 4). Small-particle miner-
alized cancellous allograft was used on the most lateral
portion of the window to allow for optimal healing
(Fig. 5). A second absorbable collagen membrane was
trimmed to cover the outside window overlapping the
edges by at least 2 to 3 mm and fixated under the palatal
flap (Figs. 6 and 7).
After surgery, medication was prescribed for the patient,
including: 1) six tablets of 250 mg azithromycin, two tab-
lets to be taken on the first day and then one tablet for the
remaining 4 days; 2) 20 tablets of 800 mg ibuprofen, one
tablet to be taken twice daily as needed for pain; 3) nine
tablets of 2 mg dexamethasone, four tablets to be taken
on the first day, two tablets on the second and third
days, and one tablet on the fourth day; and 4) 25 tablets
of 10/1,000 mg hydrocodone/acetaminophen, one tablet
to be taken three times per day as needed for pain. Healing
was uneventful, and sutures were removed after 2 weeks.
Panoramic radiographs were taken at the 2-week and 6-
month postoperative visits (Figs. 8 and 9).
Six months after the sinus augmentation, implant sur-
gery was performed under local anesthesia. A flap was re-
flected and showed good bone formation (Fig. 10).
Trephine bone core biopsies were collected, and two im-
plants{ were placed at tooth sites #2 and #3 (5.0  13
and 4.3 13mm, respectively), achieving excellent primary
stability. The patient was placed on a similar regimen of
azithromycin and ibuprofen aswith the sinus-augmentation
surgery.
Clinical Outcomes
Both core biopsies underwent histologic analyses. Masson
trichrome staining method demonstrated the maturation
process of the graft (Fig. 11). Immature osteoid is stained
red, whereas mature mineralized bone is stained blue. Be-
cause there was a significantly greater proportion of min-
eralized bone (suggesting higher bone density), it can be
inferred that the graft underwent regeneration, new bone
formation, and maturation. Hematoxylin and eosin
(H&E) staining (Fig. 12) revealed osteocytes within lacu-
nae of the mineralized bone, indicating the viability of
the mature bone.
Second-stage surgerywas performed after 5monthswith
sound stability of both implants. Three months later,
splinted porcelain fused to metal (PFM) crowns were ce-
mented on implants #2 and #3, a PFMcrownwas cemented
on implant #4, and implant #5was restoredwith a compos-
ite restoration. Final restoration was completed 6 months
after implant placement and periapical radiographs were
taken (Fig. 13).
Discussion
Comparing panoramic radiographs at 2 weeks and 6
months after the sinus-augmentation procedure revealed
minimal density change. Histologic analysis showed signif-
icant graft maturation. As such, it appears as though add-
ing rhBMP-2 directly to the allograft mixture is a viable
method for maxillary sinus augmentations. However,
larger and long-term randomized controlled trials are
needed for proper quantitative analysis and to determine
its long-term predictability. n
x Puros, Zimmer Dental.
‖ Infuse, Medtronic, Memphis, TN.
{ NobelReplace Select implants, Nobel Biocare, Yorba Linda, CA.
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Summary
Why is this case new information? j To the best of the authors’ knowledge, this is the first documented
case demonstrating the addition of rhBMP-2 directly to an allograft
mixture without an ACS, especially with concurrent histologic analysis
of the graft.
What are the keys to successful
management of this case?
j Patient case selection
j Surgical experience of the clinician
j Avoiding any perforations of the Schneiderian membrane during
surgery
j Adequate graft isolation
j Maintaining primary closure postoperatively
What are the primary limitations to
success in this case?
j To truly claim the graft regenerated at an accelerated rate with
reduced shrinkage attributable to the addition of rhBMP-2 to the
allograft, biopsies would need to be taken earlier after the grafting
procedure and compared with controls.
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